A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors
/in Dendritic Cells, Gallbladder Cancer, International Publications, Pancreatic Cancer /von 2008-01-01 / Cancer Ther 2008;6(B):955-964Dendritic cell immunotherapy for malignant gliomas
/in Dendritic Cells, Glioblastoma, International Publications /von 2008-01-01 / Rev Recent Clin Trials 2008 Jan;3(1):10-21Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line
/in Hepatocellular Carcinoma, International Publications /von 2008-01-01 / Hepatogastroenterology 2008 Jan-Feb;55(81):155-9Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients
/in International Publications, Malignant Melanoma /von 2008-01-01 / J. Immunother. 2008 Jan;31(1):101-12Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation
/in Dendritic Cells, International Publications /von 2007-12-21 / J. Leukoc. Biol. 2008 Mar;83(3):742-54Immunotherapy for metastatic prostate cancer
/in International Publications, Prostate Cancer /von 2007-12-21 / Urol. Oncol. 2008 Jul-Aug;26(4):438-44Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas
/in Glioblastoma, International Publications /von 2007-12-19 / J Transl Med 2007 Dec;5:67Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial
/in Cervical Cancer, Dendritic Cells, International Publications /von 2007-12-05 / J Virol 2008 Feb;82(4):1968-79Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma
/in Colorectal Cancer, International Publications /von 2007-12-03 / Immunol. Lett. 2008 Feb;116(1):24-32
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de